-->

Deadly medicines and organised crime: how big pharma has corrupted healthcare

"In his latest ground-breaking book, Peter C Gotzsche exposes the pharmaceutical industries and their charade of fraudulent behaviour, both in research and marketing where the morally repugnant disregard for human lives is the norm. He convincingly draws close comparisons with the tobacco congl...

Full description

Saved in:
Bibliographic Details
Main Author: Gøtzsche, Peter C.
Format: Print Book
Language:English
Published: London [u.a.] Radcliffe Publ. c 2013
Online Access: Inhaltsbeschreibung & Leseprobe
Inhaltsverzeichnis (Verlag)
Klappentext (Verlag)
Availability in Tübingen:Present in Tübingen.
UB: KB 20 A 6436
Check availability: HBZ Gateway
Subito Delivery Service: Order now.
Keywords:
Description
Summary:"In his latest ground-breaking book, Peter C Gotzsche exposes the pharmaceutical industries and their charade of fraudulent behaviour, both in research and marketing where the morally repugnant disregard for human lives is the norm. He convincingly draws close comparisons with the tobacco conglomerates, revealing the extraordinary truth behind efforts to confuse and distract the public and their politicians. The book addresses, in evidence-based detail, an extraordinary system failure caused by widespread crime, corruption, bribery and impotent drug regulation in need of radical reforms"--Publisher's description
Foreword / Richard Smith -- Foreword / Drummond Rennie -- 1. Introduction -- 2. Confessions from an insider -- Asthma deaths were caused by asthma inhalers -- shady marketing and research -- 3. Organized crime, the business model of big pharma -- Hoffman-LaRoche, the biggest drug pusher -- Hall of Shame for big pharma -- The crimes are repetitive -- It's organized crime -- 4. Very few patients benefit from the drugs they take -- 5. Clinical trials, a broken social contract with patients -- 6. Conflicts of interest at medical journals -- 7. The corruptive influence of easy money -- 8. What do thousands of doctors on industry payroll do? -- Seeding trials -- Rent a key opinion leader to "give advice" -- Rent a key opinion leader to "educate" -- 9. Hard sell -- Clinical trials are marketing in disguise -- Ghostwriting -- The marketing machine -- Hard sell ad nauseam -- Highly expensive drugs -- Excesses in hypertension -- Patient organizations -- NovoSeven for bleeding soldiers -- 10. Impotent drug regulation -- Conflicts of interest at drug agencies -- Corruption at drug agencies -- The unbearable lightness of politicians - Drug regulation builds on trust -- Inadequate testing of new drugs -- Too many warnings and too many drugs -- 11. Public access to data at drug agencies -- Our breakthrough at the EMA in 2010 -- Access to data at other drug agencies -- Deadly slimming pills -- 12. Neurontin, an epilepsy drug for everything -- 13. Merck, where the patients die first -- 14. Fraudulent celecoxib trial and other lies -- Marketing is harmful -- 15. Switching cheap drugs to expensive ones in the same patients -- Nove Nordisk switches patients to expensive insulin -- AstraZeneca switches patients to expensive me-again omeprazole -- 16. Blood glucose was fine but the patients died -- Novo Nordisk interferes with an academic publication -- 17. Psychiatry, the drug industry's paradise -- Are we all crazy or what? -- Psychiatrists as drug pushers -- The chemical imbalance hoax -- Screening for psychiatric disorders -- Unhappy pills -- Prozac, a terrible Eli Lilly drug turned into a blockbuster -- Exercise is a good intervention -- Further lies about happy pills -- 18. Pushing children into suicide with happy pills -- Glaxo study 329 -- Concealing suicides and suicide attempts in clinical trials -- Lundbeck's evergreening of citalopram -- 19. Intimidation, threats, and violence to protect sales -- 20. Busting the industry myths -- 21. General system failure calls for a revolution -- Our drugs kill us -- How much medicine do we really need and at what cost? -- For-profit is the wrong model -- Clinical trials -- Drug regulatory agencies -- Drug formulary and guideline committees -- Drug marketing -- Doctors and their organizations -- Patients and their organizations -- Medical journals -- Journalists -- 22. Having the last laugh at big pharma -- Money doesn't smell -- Creating diseases
Item Description:Literaturangaben
Physical Description:XII, 310 S. Ill., graph. Darst. 24 cm
ISBN:9781846198847